BACE-1 inhibition by a series of psi[CH2NH] reduced amide isosteres
Coburn, C.A., Stachel, S.J., Jones, K.G., Steele, T.G., Rush, D.M., DiMuzio, J., Pietrak, B.L., Lai, M.T., Huang, Q., Lineberger, J., Jin, L., Munshi, S., Holloway, K.M., Espeseth, A., Simon, A., Hazuda, D., Graham, S.L., Vacca, J.P.(2006) Bioorg Med Chem Lett 16: 3635-3638
- PubMed: 16690314 
- DOI: https://doi.org/10.1016/j.bmcl.2006.04.076
- Primary Citation of Related Structures:  
2QZL - PubMed Abstract: 
A series of beta-site amyloid precursor protein cleaving enzyme (BACE-1) inhibitors containing a psi(CH2NH) reduced amide bond were synthesized. Incorporation of this reduced amide isostere as a non-cleavable peptide surrogate afforded inhibitors possessing low nanomolar potencies in both an enzymatic and cell-based assay.
Organizational Affiliation: 
Department of Medicinal Chemistry, Merck Research Laboratories, PO Box 4, West Point, PA 19486, USA. craig_coburn@merck.com